Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on the Safety and Tolerability of Exidavnemab in Patients with Mild to Moderate Parkinson's Disease
PolandStudy of sulthiame combined with oral appliance therapy for patients with obstructive sleep apnea who have incomplete response to oral appliance treatment alone
DenmarkStudy on the Safety and Efficacy of ARGX-119 for Adults with Amyotrophic Lateral Sclerosis (ALS)
BelgiumStudy on the Safety and Tolerability of Guanabenz in Children with Vanishing White Matter Disease
The NetherlandsStudy on the Effects of Glycerol Phenylbutyrate in Patients with Corticobasal Syndrome
GermanyStudy of Berubicin versus Lomustine in adult patients with recurrent Glioblastoma Multiforme after first-line treatment failure
FranceStudy on the Effects of Losartan Potassium on Brain Tumors in Patients with Glioblastoma or Brain Metastases from Non-Small-Cell Lung Cancer
NorwayStudy on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis
AustriaStudy on the Safety and Effects of Fasudil Hydrochloride for Patients with Parkinson's Disease
GermanyStudy on DMD06-MAB Injection for Duchenne Muscular Dystrophy in Non-Ambulant Patients
ItalyStudy on Gene Therapy with Atidarsagene Autotemcel for Patients with Metachromatic Leukodystrophy
ItalyStudy of NMD670 tablets to improve muscle strength in adults with Type 3 spinal muscular atrophy who can walk
BelgiumThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
